PHARMACIA & UPJOHN'S CEEON HEPARIN COATED INTRAOCULAR LENS LABELING SHOULD NOT INCLUDE REDUCED FOREIGN BODY REACTION CLAIM, OPHTHALMIC PANEL SAYS
This article was originally published in The Gray Sheet
Executive Summary
Pharmacia & Upjohn's CeeOn heparin surface modified (HSM) posterior chamber intraocular lenses for treatment of aphakia should not include a blanket labeling claim of reduced foreign body reactions compared to non-HSM lenses, FDA's Ophthalmic Devices Panel concluded at an Oct. 20 meeting in Gaithersburg, Maryland.